Invention Grant
US08676283B2 Method and apparatus to compensate for melanin and hemoglobin variation in determination of a measure of a glycation end-product or disease state using tissue fluorescence 失效
使用组织荧光法测定糖基化终产物或疾病状态的方法和装置来补偿黑色素和血红蛋白变异

  • Patent Title: Method and apparatus to compensate for melanin and hemoglobin variation in determination of a measure of a glycation end-product or disease state using tissue fluorescence
  • Patent Title (中): 使用组织荧光法测定糖基化终产物或疾病状态的方法和装置来补偿黑色素和血红蛋白变异
  • Application No.: US11964665
    Application Date: 2007-12-26
  • Publication No.: US08676283B2
    Publication Date: 2014-03-18
  • Inventor: Nathaniel MatterMarwood Neal EdigerJohn D Maynard
  • Applicant: Nathaniel MatterMarwood Neal EdigerJohn D Maynard
  • Applicant Address: US NM Albuquerque
  • Assignee: VeraLight, Inc.
  • Current Assignee: VeraLight, Inc.
  • Current Assignee Address: US NM Albuquerque
  • Agent V. Gerald Grafe
  • Main IPC: A61B5/1455
  • IPC: A61B5/1455
Method and apparatus to compensate for melanin and hemoglobin variation in determination of a measure of a glycation end-product or disease state using tissue fluorescence
Abstract:
A method of determining a measure of a tissue state (e.g., glycation end-product or disease state) in an individual is disclosed. A portion of the skin of the individual is illuminated with excitation light, then light emitted by the tissue due to fluorescence of a chemical with the tissue responsive to the excitation light is detected. The detected light can be combined with a model relating fluorescence with a measure of tissue state to determine a tissue state. The invention can illuminate the skin and detect responsive light over a time that spans a plurality of cardiac cycles of the individual, which can, as an example, help mitigate the effects of time-varying signals such as those due to hemoglobin. The invention can also determine the amount of light to be directed to the skin, for example by controlling the time that a light source is energized. The amount of illumination light can be determined from a skin reflectance characteristic such as pigmentation or melanin in the skin. Controlling the amount of light directed to the tissue can reduce the dynamic range required of a corresponding optical system, for example by allowing a single system to accurately measure individuals with very light skin and individuals with very dark skin.
Information query
Patent Agency Ranking
0/0